Teva Reports Fourth Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Teva Pharma (TEVA) Gains 7.5% Following Results
February 12, 2020 9:33 AM ESTTeva Pharma (NYSE: TEVA) gains 7.5% off the open following results.
... MoreUPDATE: Teva Pharma (TEVA) Tops Q4 EPS by 1c, Offers FY20 Guidance
February 12, 2020 7:01 AM EST(Updated - February 12, 2020 7:05 AM EST)
Teva Pharma (NYSE: TEVA) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.35 billion.
2020 business outlook:
Revenues are... More
